5-bromopyridin-3-ol;tert-butyl 6-(5-hydroxy-3-pyridinyl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxylate;tert-butyl 6-[5-[2-(2-oxo-1,3-oxazolidin-3-yl)ethoxy]-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxylate;tert-butyl 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxylate;3-(2-hydroxyethyl)-1,3-oxazolidin-2-one;6-[5-[2-(2-oxo-1,3-oxazolidin-3-yl)ethoxy]-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide;3-[2-[[5-(5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)-3-pyridinyl]oxy]ethyl]-1,3-oxazolidin-2-one

C107H132BBrN20O23 — CID 161311217

About 5-bromopyridin-3-ol;tert-butyl 6-(5-hydroxy-3-pyridinyl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxylate;tert-butyl 6-[5-[2-(2-oxo-1,3-oxazolidin-3-yl)ethoxy]-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxylate;tert-butyl 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxylate;3-(2-hydroxyethyl)-1,3-oxazolidin-2-one;6-[5-[2-(2-oxo-1,3-oxazolidin-3-yl)ethoxy]-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide;3-[2-[[5-(5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)-3-pyridinyl]oxy]ethyl]-1,3-oxazolidin-2-one

5-bromopyridin-3-ol;tert-butyl 6-(5-hydroxy-3-pyridinyl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxylate;tert-butyl 6-[5-[2-(2-oxo-1,3-oxazolidin-3-yl)ethoxy]-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxylate;tert-butyl 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxylate;3-(2-hydroxyethyl)-1,3-oxazolidin-2-one;6-[5-[2-(2-oxo-1,3-oxazolidin-3-yl)ethoxy]-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide;3-[2-[[5-(5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)-3-pyridinyl]oxy]ethyl]-1,3-oxazolidin-2-one (PubChem CID 161311217) has the molecular formula C107H132BBrN20O23 and a molecular weight of 2157.07 g/mol. Its IUPAC name is 5-bromopyridin-3-ol;tert-butyl 6-(5-hydroxy-3-pyridinyl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxylate;tert-butyl 6-[5-[2-(2-oxo-1,3-oxazolidin-3-yl)ethoxy]-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxylate;tert-butyl 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxylate;3-(2-hydroxyethyl)-1,3-oxazolidin-2-one;6-[5-[2-(2-oxo-1,3-oxazolidin-3-yl)ethoxy]-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide;3-[2-[[5-(5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)-3-pyridinyl]oxy]ethyl]-1,3-oxazolidin-2-one.

Molecular Properties

• Compound Name: 5-bromopyridin-3-ol;tert-butyl 6-(5-hydroxy-3-pyridinyl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxylate;tert-butyl 6-[5-[2-(2-oxo-1,3-oxazolidin-3-yl)ethoxy]-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxylate;tert-butyl 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxylate;3-(2-hydroxyethyl)-1,3-oxazolidin-2-one;6-[5-[2-(2-oxo-1,3-oxazolidin-3-yl)ethoxy]-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide;3-[2-[[5-(5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)-3-pyridinyl]oxy]ethyl]-1,3-oxazolidin-2-one
• PubChem CID: 161311217
• Molecular Formula: C107H132BBrN20O23
• Molecular Weight: 2157.07 g/mol
• Exact Mass: 2154.91
• IUPAC Name: 5-bromopyridin-3-ol;tert-butyl 6-(5-hydroxy-3-pyridinyl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxylate;tert-butyl 6-[5-[2-(2-oxo-1,3-oxazolidin-3-yl)ethoxy]-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxylate;tert-butyl 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxylate;3-(2-hydroxyethyl)-1,3-oxazolidin-2-one;6-[5-[2-(2-oxo-1,3-oxazolidin-3-yl)ethoxy]-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide;3-[2-[[5-(5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)-3-pyridinyl]oxy]ethyl]-1,3-oxazolidin-2-one
• SMILES: CC(C)(C)OC(=O)N1CCCc2cc(-c3cncc(O)c3)cnc21.CC(C)(C)OC(=O)N1CCCc2cc(-c3cncc(OCCN4CCOC4=O)c3)cnc21.CC(C)(C)OC(=O)N1CCCc2cc(B3OC(C)(C)C(C)(C)O3)cnc21.NC(=O)N1CCCc2cc(-c3cncc(OCCN4CCOC4=O)c3)cnc21.O=C1OCCN1CCO.O=C1OCCN1CCOc1cncc(-c2cnc3c(c2)CCCN3)c1.Oc1cncc(Br)c1
• InChI: InChI=1S/C23H28N4O5.C19H29BN2O4.C19H21N5O4.C18H20N4O3.C18H21N3O3.C5H4BrNO.C5H9NO3/c1-23(2,3)32-22(29)27-6-4-5-16-11-17(14-25-20(16)27)18-12-19(15-24-13-18)30-9-7-26-8-10-31-21(26)28;1-17(2,3)24-16(23)22-10-8-9-13-11-14(12-21-15(13)22)20-25-18(4,5)19(6,7)26-20;20-18(25)24-3-1-2-13-8-14(11-22-17(13)24)15-9-16(12-21-10-15)27-6-4-23-5-7-28-19(23)26;23-18-22(5-7-25-18)4-6-24-16-9-15(10-19-12-16)14-8-13-2-1-3-20-17(13)21-11-14;1-18(2,3)24-17(23)21-6-4-5-12-7-13(10-20-16(12)21)14-8-15(22)11-19-9-14;6-4-1-5(8)3-7-2-4;7-3-1-6-2-4-9-5(6)8/h11-15H,4-10H2,1-3H3;11-12H,8-10H2,1-7H3;8-12H,1-7H2,(H2,20,25);8-12H,1-7H2,(H,20,21);7-11,22H,4-6H2,1-3H3;1-3,8H;7H,1-4H2
• InChIKey: VIXJEQLYSRDGNM-UHFFFAOYSA-N
• XLogP: 15.39
• TPSA: 500.88 Ų
• H-Bond Donors: 5
• H-Bond Acceptors: 34
• Rotatable Bonds: 19
• Heavy Atoms: 152
• Complexity: —

Lipinski Rule of Five

3 violations

Rule	Value
MW ≤ 500	2157.07
LogP ≤ 5	15.39
H-Bond Donors ≤ 5	5
H-Bond Acceptors ≤ 10	34

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of 5-bromopyridin-3-ol;tert-butyl 6-(5-hydroxy-3-pyridinyl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxylate;tert-butyl 6-[5-[2-(2-oxo-1,3-oxazolidin-3-yl)ethoxy]-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxylate;tert-butyl 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxylate;3-(2-hydroxyethyl)-1,3-oxazolidin-2-one;6-[5-[2-(2-oxo-1,3-oxazolidin-3-yl)ethoxy]-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide;3-[2-[[5-(5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)-3-pyridinyl]oxy]ethyl]-1,3-oxazolidin-2-one?

The IUPAC name of 5-bromopyridin-3-ol;tert-butyl 6-(5-hydroxy-3-pyridinyl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxylate;tert-butyl 6-[5-[2-(2-oxo-1,3-oxazolidin-3-yl)ethoxy]-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxylate;tert-butyl 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxylate;3-(2-hydroxyethyl)-1,3-oxazolidin-2-one;6-[5-[2-(2-oxo-1,3-oxazolidin-3-yl)ethoxy]-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide;3-[2-[[5-(5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)-3-pyridinyl]oxy]ethyl]-1,3-oxazolidin-2-one (CID 161311217) is 5-bromopyridin-3-ol;tert-butyl 6-(5-hydroxy-3-pyridinyl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxylate;tert-butyl 6-[5-[2-(2-oxo-1,3-oxazolidin-3-yl)ethoxy]-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxylate;tert-butyl 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxylate;3-(2-hydroxyethyl)-1,3-oxazolidin-2-one;6-[5-[2-(2-oxo-1,3-oxazolidin-3-yl)ethoxy]-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide;3-[2-[[5-(5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)-3-pyridinyl]oxy]ethyl]-1,3-oxazolidin-2-one.

What is the SMILES notation for 5-bromopyridin-3-ol;tert-butyl 6-(5-hydroxy-3-pyridinyl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxylate;tert-butyl 6-[5-[2-(2-oxo-1,3-oxazolidin-3-yl)ethoxy]-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxylate;tert-butyl 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxylate;3-(2-hydroxyethyl)-1,3-oxazolidin-2-one;6-[5-[2-(2-oxo-1,3-oxazolidin-3-yl)ethoxy]-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide;3-[2-[[5-(5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)-3-pyridinyl]oxy]ethyl]-1,3-oxazolidin-2-one?

The canonical SMILES for 5-bromopyridin-3-ol;tert-butyl 6-(5-hydroxy-3-pyridinyl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxylate;tert-butyl 6-[5-[2-(2-oxo-1,3-oxazolidin-3-yl)ethoxy]-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxylate;tert-butyl 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxylate;3-(2-hydroxyethyl)-1,3-oxazolidin-2-one;6-[5-[2-(2-oxo-1,3-oxazolidin-3-yl)ethoxy]-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide;3-[2-[[5-(5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)-3-pyridinyl]oxy]ethyl]-1,3-oxazolidin-2-one is CC(C)(C)OC(=O)N1CCCc2cc(-c3cncc(O)c3)cnc21.CC(C)(C)OC(=O)N1CCCc2cc(-c3cncc(OCCN4CCOC4=O)c3)cnc21.CC(C)(C)OC(=O)N1CCCc2cc(B3OC(C)(C)C(C)(C)O3)cnc21.NC(=O)N1CCCc2cc(-c3cncc(OCCN4CCOC4=O)c3)cnc21.O=C1OCCN1CCO.O=C1OCCN1CCOc1cncc(-c2cnc3c(c2)CCCN3)c1.Oc1cncc(Br)c1.

What is the InChIKey of 5-bromopyridin-3-ol;tert-butyl 6-(5-hydroxy-3-pyridinyl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxylate;tert-butyl 6-[5-[2-(2-oxo-1,3-oxazolidin-3-yl)ethoxy]-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxylate;tert-butyl 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxylate;3-(2-hydroxyethyl)-1,3-oxazolidin-2-one;6-[5-[2-(2-oxo-1,3-oxazolidin-3-yl)ethoxy]-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide;3-[2-[[5-(5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)-3-pyridinyl]oxy]ethyl]-1,3-oxazolidin-2-one?

The InChIKey is VIXJEQLYSRDGNM-UHFFFAOYSA-N. The full InChI is InChI=1S/C23H28N4O5.C19H29BN2O4.C19H21N5O4.C18H20N4O3.C18H21N3O3.C5H4BrNO.C5H9NO3/c1-23(2,3)32-22(29)27-6-4-5-16-11-17(14-25-20(16)27)18-12-19(15-24-13-18)30-9-7-26-8-10-31-21(26)28;1-17(2,3)24-16(23)22-10-8-9-13-11-14(12-21-15(13)22)20-25-18(4,5)19(6,7)26-20;20-18(25)24-3-1-2-13-8-14(11-22-17(13)24)15-9-16(12-21-10-15)27-6-4-23-5-7-28-19(23)26;23-18-22(5-7-25-18)4-6-24-16-9-15(10-19-12-16)14-8-13-2-1-3-20-17(13)21-11-14;1-18(2,3)24-17(23)21-6-4-5-12-7-13(10-20-16(12)21)14-8-15(22)11-19-9-14;6-4-1-5(8)3-7-2-4;7-3-1-6-2-4-9-5(6)8/h11-15H,4-10H2,1-3H3;11-12H,8-10H2,1-7H3;8-12H,1-7H2,(H2,20,25);8-12H,1-7H2,(H,20,21);7-11,22H,4-6H2,1-3H3;1-3,8H;7H,1-4H2.

What are the key properties of 5-bromopyridin-3-ol;tert-butyl 6-(5-hydroxy-3-pyridinyl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxylate;tert-butyl 6-[5-[2-(2-oxo-1,3-oxazolidin-3-yl)ethoxy]-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxylate;tert-butyl 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxylate;3-(2-hydroxyethyl)-1,3-oxazolidin-2-one;6-[5-[2-(2-oxo-1,3-oxazolidin-3-yl)ethoxy]-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide;3-[2-[[5-(5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)-3-pyridinyl]oxy]ethyl]-1,3-oxazolidin-2-one?

5-bromopyridin-3-ol;tert-butyl 6-(5-hydroxy-3-pyridinyl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxylate;tert-butyl 6-[5-[2-(2-oxo-1,3-oxazolidin-3-yl)ethoxy]-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxylate;tert-butyl 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxylate;3-(2-hydroxyethyl)-1,3-oxazolidin-2-one;6-[5-[2-(2-oxo-1,3-oxazolidin-3-yl)ethoxy]-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide;3-[2-[[5-(5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)-3-pyridinyl]oxy]ethyl]-1,3-oxazolidin-2-one has a molecular weight of 2157.07 g/mol, XLogP of 15.39, 19 rotatable bonds, 5 hydrogen bond donors, and 34 hydrogen bond acceptors.

Where does this data come from?

All data for 5-bromopyridin-3-ol;tert-butyl 6-(5-hydroxy-3-pyridinyl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxylate;tert-butyl 6-[5-[2-(2-oxo-1,3-oxazolidin-3-yl)ethoxy]-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxylate;tert-butyl 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxylate;3-(2-hydroxyethyl)-1,3-oxazolidin-2-one;6-[5-[2-(2-oxo-1,3-oxazolidin-3-yl)ethoxy]-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide;3-[2-[[5-(5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)-3-pyridinyl]oxy]ethyl]-1,3-oxazolidin-2-one is sourced from PubChem (CID 161311217), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).